AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 278: L1082-L1090, 2000;
1040-0605/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pryhuber, G. S.
Right arrow Articles by Nahm, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pryhuber, G. S.
Right arrow Articles by Nahm, M. H.
Vol. 278, Issue 5, L1082-L1090, May 2000

Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury

Gloria S. Pryhuber1,2, David P. O'Brien1,3, Raymond Baggs2, Richard Phipps2,4, Heidie Huyck1, Inaki Sanz3, and Moon H. Nahm1,3,4,5

Departments of 1 Pediatrics, 2 Environmental Medicine, 3 Medicine, and 5 Pathology and 4 The Cancer Center, Strong Children's Research Center, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Hyperoxic lung injury, believed to be mediated by reactive oxygen species, inflammatory cell activation, and release of cytotoxic cytokines, complicates the care of many critically ill patients. The cytokine tumor necrosis factor (TNF)-alpha is induced in lungs exposed to high concentrations of oxygen; however, its contribution to hyperoxia-induced lung injury remains unclear. Both TNF-alpha treatment and blockade with anti-TNF antibodies increased survival in mice exposed to hyperoxia. In the current study, to determine if pulmonary oxygen toxicity is dependent on either of the TNF receptors, type I (TNFR-I) or type II (TNFR-II), TNFR-I or TNFR-II gene-ablated [(-/-)] mice and wild-type control mice (WT; C57BL/6) were studied in >95% oxygen. There was no difference in average length of survival, although early survival was better for TNFR-I(-/-) mice than for either TNFR-II(-/-) or WT mice. At 48 h of hyperoxia, slightly more alveolar septal thickening and peribronchiolar and periarteriolar edema were detected in WT than in TNFR-I(-/-) lungs. By 84 h of oxygen exposure, TNFR-I(-/-) mice demonstrated greater alveolar debris, inflammation, and edema than WT mice. TNFR-I was necessary for induction of cytokine interleukin (IL)-1beta , IL-1 receptor antagonist, chemokine macrophage inflammatory protein (MIP)-1beta , MIP-2, interferon-gamma -induced protein-10 (IP-10), and monocyte chemoattractant protein (MCP)-1 mRNA in response to intratracheal administration of recombinant murine TNF-alpha . However, IL-1beta , IL-6, macrophage migration inhibitory factor, MIP-1alpha , MIP-2, and MCP-1 mRNAs were comparably induced by hyperoxia in TNFR-I(-/-) and WT lungs. In contrast, mRNA for manganese superoxide dismutase and intercellular adhesion molecule-1 were induced by hyperoxia only in WT mice. Differences in early survival and toxicity suggest that pulmonary oxygen toxicity is in part mediated by TNFR-I. However, induction of specific cytokine and chemokine mRNA and lethality in response to severe hyperoxia was independent of TNFR-I expression. The current study supports the prediction that therapeutic efforts to block TNF-alpha receptor function will not protect against pulmonary oxygen toxicity.

oxygen toxicity; C57BL/6 mice; tumor necrosis factor receptor I knockout; tumor necrosis factor receptor II; lung inflammation; manganese superoxide dismutase; intercellular adhesion molecule-1


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Yamada, H. Kubo, S. Kobayashi, K. Ishizawa, and H. Sasaki
Interferon-{gamma}: a key contributor to hyperoxia-induced lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1042 - L1047.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Wang, S. W. Ryter, C. Dai, Z.-L. Tang, S. C. Watkins, X.-M. Yin, R. Song, and A. M. K. Choi
Necrotic Cell Death in Response to Oxidant Stress Involves the Activation of the Apoptogenic Caspase-8/Bid Pathway
J. Biol. Chem., August 1, 2003; 278(31): 29184 - 29191.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
G. S. Pryhuber, H. L. Huyck, R. Baggs, G. Oberdorster, and J. N. Finkelstein
Induction of Chemokines by Low-Dose Intratracheal Silica Is Reduced in TNFR I (p55) Null Mice
Toxicol. Sci., March 1, 2003; 72(1): 150 - 157.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. J. Janatpour, S. Hudak, M. Sathe, J. D. Sedgwick, and L. M. McEvoy
Tumor Necrosis Factor-dependent Segmental Control of MIG Expression by High Endothelial Venules in Inflamed Lymph Nodes Regulates Monocyte Recruitment
J. Exp. Med., November 5, 2001; 194(9): 1375 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H.-Y. Cho, L.-Y. Zhang, and S. R. Kleeberger
Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-{alpha} receptors
Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L537 - L546.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online